Our client is revolutionising cardiac care with their groundbreaking innovation. They have pioneered a fully automated, AI-driven image analysis system that identifies and measures atherosclerosis from high-resolution OCT images, providing doctors with unprecedented insights into patients’ conditions during stenting procedures. Their cutting-edge software offers real-time decision support during these critical interventions and enabling preventive treatments. It can also enhance the efficacy measures in clinical trials for developing new drugs and stents. With one of the largest curated OCT image datasets, their software matches the current gold standard of histology for clinicians in identifying and measuring atherosclerosis from coronary artery images.

They seek an experienced, entrepreneurial, and forward-thinking Non-Executive Chair to join their dynamic team to transform cardiac care. This hybrid role combines traditional chair responsibilities with a strategic emphasis on business development and fundraising.

The successful candidate will be required to attend team meetings based in Cambridge, UK. They will understand the early-stage nature of the company and the corresponding remuneration structure. Compensation will be tied to securing external seed financing, with an option for an unapproved share package from the outset.